0001090872-20-000008.txt : 20200521 0001090872-20-000008.hdr.sgml : 20200521 20200521160656 ACCESSION NUMBER: 0001090872-20-000008 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20200521 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGILENT TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001090872 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770518772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15405 FILM NUMBER: 20901915 BUSINESS ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: (408) 345-8886 MAIL ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD, MS 1A-LC STREET 2: P.O. BOX 58059 CITY: SANTA CLARA STATE: CA ZIP: 95052-8059 FORMER COMPANY: FORMER CONFORMED NAME: AGILENT TECHNOLOGIES INC DATE OF NAME CHANGE: 19990816 FORMER COMPANY: FORMER CONFORMED NAME: HP MEASUREMENT INC DATE OF NAME CHANGE: 19990716 8-K 1 form8-kxq220pressrelea.htm 8-K Document
false0001090872 0001090872 2020-05-21 2020-05-21
 
 
 






UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 21, 2020
 
AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter)
 
 
Delaware
 
 

001-15405
 
 

77-0518772
 
(State or other jurisdiction
 
(Commission
 
(IRS Employer
of incorporation)
 
File Number)
 
Identification No.)
 
5301 Stevens Creek Boulevard, Santa Clara, CA 95051
(Address of Principal Executive Offices) (Zip Code)
 
Registrant’s telephone number, including area code (800) 227-9770
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
 
TITLE OF EACH CLASS
 
 
TRADING SYMBOL(S)
 
NAME OF EACH EXCHANGE ON WHICH REGISTERED

COMMON STOCK, $0.01 PAR VALUE
 
 

A
 
 

New York Stock Exchange
 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 


 
 
 


Item 2.02.              Results of Operations and Financial Condition.
 
The information in this Item 2.02 of Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
 
On May 21, 2020, Agilent Technologies, Inc. (the “Company”) issued its press release announcing financial results for the second fiscal quarter ended April 30, 2020.  A copy of this press release is attached as Exhibit 99.1.
 
The Company provides non-GAAP financial information in order to provide meaningful supplemental information regarding its operational performance and to enhance its investors’ overall understanding of its core current financial performance and its prospects for the future.  The Company believes that its investors benefit from seeing its results “through the eyes” of management in addition to the GAAP presentation.  Management measures segment and enterprise performance using measures such as those that are disclosed in this release.  This information facilitates management’s internal comparisons to the Company’s historical operating results and comparisons to competitors’ operating results.  Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operations decision making.  Historically, the Company has reported similar non-GAAP information to its investors and believes that the inclusion of comparative numbers provides consistency in its financial reporting.
 
This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States.  It excludes items, such as restructuring and amortization, that may have a material effect on the Company’s expenses and earnings per share calculated in accordance with GAAP.  Management monitors these items to ensure that expenses are in line with expectations and that the Company's GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the Company.  The non-GAAP information the Company provides may be different from the non-GAAP information provided by other companies.
 
Additional explanation of non-GAAP information is provided in Exhibit 99.1.


Item 9.01.              Financial Statements and Exhibits.
 
(d) Exhibits
 
The following is furnished as an exhibit to this report and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended:
 
Exhibit No.
 
Description
 
 
 

 
Press release announcing financial results for the second fiscal quarter ended April 30, 2020
104

 
Cover page interactive data file (embedded within the Inline XBRL document)




2

 
 
 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
By:
/s/ P. Diana Chiu
 
Name:
P. Diana Chiu
 
Title:
Vice President, Assistant General Counsel
and Assistant Secretary
 
 
 
 
 
 
 
Date: May 21, 2020
 







3

 
 
 
 EX-99.1 2 exhibit991-q220pressre.htm EXHIBIT 99.1 Exhibit


Exhibit 99.1

Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results
Highlights:
•
Revenue of $1.24 billion represents flat reported growth, down 1.7% on a core(1) basis
•
GAAP net income of $101 million, or 32 cents per share
•
Non-GAAP(2) net income of $223 million, or 71 cents per share
•
Strong operating cash flow of $313 million, up 24% versus prior year
SANTA CLARA, Calif., May 21, 2020 - Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.24 billion for the second quarter ended April 30, 2020, equal to revenue reported for the second quarter of 2019 and down 1.7% on a core(1) basis.
Second-quarter GAAP net income was $101 million, or 32 cents per share. This compares with $182 million, or 57 cents per share, in the second quarter of fiscal year 2019. Non-GAAP(2) net income was $223 million, or 71 cents per share, during the quarter compared with $228 million, or 71 cents per share, during the second quarter a year ago.
“Our business was tracking well into late March when we experienced significant disruption in the U.S. and Europe as customers closed or restricted access to their facilities to slow the spread of COVID-19,” said Mike McMullen, Agilent president and CEO.
“I’m incredibly proud of how the Agilent team has taken quick, decisive action to ensure the safety of our employees, keep our operations up and running efficiently, and support our customers around the world. I believe we are well-positioned to face the challenges brought on by COVID-19 given our focus on growth, a resilient business model, a strong balance sheet, and most important, our outstanding team.”
Financial Highlights
Life Sciences and Applied Markets Group
Second-quarter revenue of $526 million from Agilent’s Life Sciences and Applied Markets Group (LSAG) was down 1% year over year (down 7% on a core(1) basis). LSAG’s operating margin was 18.7%.
 
Agilent CrossLab Group
Second-quarter revenue of $449 million from the Agilent CrossLab Group (ACG) declined 1% year over year (up 1% on a core(1) basis). ACG’s operating margin was 27.2%.


1


Diagnostics and Genomics Group
Second-quarter revenue of $263 million from Agilent’s Diagnostics and Genomics Group (DGG) grew 3% year over year (up 5% on a core(1) basis). DGG’s operating margin was 21.6%.
Conference Call
Agilent’s management will present additional details regarding the company’s second-quarter 2020 financial results on a conference call with investors today at 1:30 p.m. PST. This event will be webcast live in listen-only mode. Listeners may log on at www.investor.agilent.com and select “Q2 2020 Agilent Technologies Inc. Earnings Conference Call” in the “News & Events - Events” section. The webcast will remain available on the company’s website for 90 days. Additional financial information can be found at www.investor.agilent.com by selecting “Financial Summary” in the “Financials” section.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent’s growth prospects, business model and financial results and the impact of COVID-19. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent’s customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing, and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; the adverse impacts of and risks posed by the COVID-19 pandemic and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q for the quarter ended January 31, 2020. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

2


(1) Core revenue growth excludes the impact of currency and acquisitions and divestitures within the past 12 months. Core revenue is a non-GAAP measure. A reconciliation between Q2 FY20 GAAP revenue and core revenue is set forth on page 6 of the attached tables along with additional information regarding the use of this non-GAAP measure.
(2) Non-GAAP net income and non-GAAP earnings per share primarily exclude the impacts of non-cash asset impairments, intangibles, amortization, transformational initiatives and acquisition and integration costs. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations and which are either isolated or are not expected to occur again with any regularity or predictability including the impact of the 2017 Tax Act. A reconciliation between non-GAAP net income and GAAP net income is set forth on page 4 of the attached tables along with additional information regarding the use of this non-GAAP measure.
# # # # #
INVESTOR CONTACT:                        
Ankur Dhingra                            
+1 408-345-8948                        
ankur_dhingra@agilent.com                    

MEDIA CONTACT:
Tom Beermann
+1 408-553-2914
tom.beermann@agilent.com


3


AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
April 30
 
April 30
 
 
 
2020
 
2019
 
2020
 
2019
 
 
 
 
 
 
 
 
 
 
 
Net revenue
 
$
1,238

 
$
1,238

 
$
2,595

 
$
2,522

 
 
 
 
 
 
 
 
 
 
 
Costs and expenses:
 
 
 
 
 
 
 
 
 
Cost of products and services
 
581

 
569

 
1,215

 
1,146

 
Research and development
 
197

 
99

 
301

 
201

 
Selling, general and administrative
 
358

 
354

 
762

 
709

 
Total costs and expenses
 
1,136

 
1,022

 
2,278

 
2,056

 
 
 
 
 
 
 
 
 
 
 
Income from operations
 
102

 
216

 
317

 
466

 
 
 
 
 
 
 
 
 
 
 
Interest income
 
3

 
10

 
6

 
20

 
Interest expense
 
(20
)
 
(17
)
 
(40
)
 
(35
)
 
Other income (expense), net
 
36

 
9

 
57

 
15

 
 
 
 
 
 
 
 
 
 
 
Income before taxes
 
121

 
218

 
340

 
466

 
 
 
 
 
 
 
 
 
 
 
Provision for (benefit from) income taxes
 
20

 
36

 
42

 
(220
)
 
 
 
 
 
 
 
 
 
 
 
Net income
 
$
101

 
$
182

 
$
298

 
$
686

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income per share:
 
 
 
 
 
 
 
 
 
Basic
 
$
0.33

 
$
0.57

 
$
0.96

 
$
2.16

 
Diluted
 
$
0.32

 
$
0.57

 
$
0.95

 
$
2.13

 
 
 
 
 
 
 
 
 
 
 
Weighted average shares used in computing net income per share:
 
 
 
 
 
 
 
 
 
Basic
 
309

 
317

 
310

 
318

 
Diluted
 
312

 
321

 
313

 
322

 
 
 
 
 
 
 
 
 
 
 




The preliminary income statement is estimated based on our current information.


1


AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEET
(In millions, except par value and share amounts)
(Unaudited)
PRELIMINARY
 
 
April 30,
2020
 
October 31,
2019
ASSETS
 
 

 
 

Current assets:
 
 

 
 

Cash and cash equivalents
 
$
1,324

 
$
1,382

Accounts receivable, net
 
886

 
930

Inventory
 
750

 
679

Other current assets
 
211

 
198

Total current assets
 
3,171

 
3,189

 
 
 
 
 
Property, plant and equipment, net
 
836

 
850

Goodwill and other intangible assets, net
 
4,503

 
4,700

Long-term investments
 
141

 
102

Other assets
 
804

 
611

Total assets
 
$
9,455

 
$
9,452

 
 
 
 
 
LIABILITIES AND EQUITY
 
 

 
 

 
 
 
 
 
Current liabilities:
 
 

 
 

Accounts payable
 
$
333

 
$
354

Employee compensation and benefits
 
280

 
334

Deferred revenue
 
399

 
336

Short-term debt
 
700

 
616

Other accrued liabilities
 
233

 
440

Total current liabilities
 
1,945

 
2,080

 
 
 
 
 
Long-term debt
 
1,788

 
1,791

Retirement and post-retirement benefits
 
340

 
360

Other long-term liabilities
 
614

 
473

Total liabilities
 
4,687

 
4,704

 
 
 
 
 
Total Equity:
 
 

 
 

Stockholders' equity:
 
 

 
 

Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding
 
—

 
—

Common stock; $0.01 par value; 2 billion shares authorized; 308 million shares at April 30, 2020 and 309 million shares at October 31, 2019, issued
 
3

 
3

Additional paid-in-capital
 
5,288

 
5,277

Retained earnings (accumulated deficit)
 
15

 
(18
)
Accumulated other comprehensive loss
 
(538
)
 
(514
)
Total stockholders' equity
 
4,768

 
4,748

Total liabilities and equity
 
$
9,455

 
$
9,452

 


The preliminary balance sheet is estimated based on our current information.

2


AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(In millions)
(Unaudited)
PRELIMINARY
 
 
Six Months Ended
 
 
April 30,
 
 
2020
 
2019
Cash flows from operating activities:
 
 

 
 
Net income
 
$
298

 
$
686

Adjustments to reconcile net income to net cash provided by (used in) operating activities:
 
 
 
 
Depreciation and amortization
 
155

 
107

Share-based compensation
 
44

 
40

Excess and obsolete inventory related charges
 
9

 
7

Asset impairment charges
 
99

 
—

Unrealized gain on equity securities
 
(27
)
 
(1
)
Other non-cash expenses, net
 
3

 
3

Changes in assets and liabilities:
 
 
 
 
Accounts receivable, net
 
25

 
(17
)
Inventory
 
(85
)
 
(21
)
Accounts payable
 
(10
)
 
(8
)
Employee compensation and benefits
 
(50
)
 
(13
)
Other assets and liabilities
 
(207
)
 
(318
)
Net cash provided by operating activities (a)
 
254

 
465

 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
Investments in property, plant and equipment
 
(67
)
 
(78
)
Payment to acquire fair value investments
 
(18
)
 
(18
)
Payment in exchange for convertible note
 
(3
)
 
(2
)
Acquisition of businesses and intangible assets, net of cash acquired
 
—

 
(248
)
Net cash used in investing activities
 
(88
)
 
(346
)
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
Issuance of common stock under employee stock plans
 
32

 
33

Payment of taxes related to net share settlement of equity awards
 
(33
)
 
(14
)
Payment of dividends
 
(111
)
 
(104
)
Proceeds from revolving credit facility
 
798

 
—

Repayment of revolving credit facility
 
(713
)
 
—

Repayment of finance lease
 
(4
)
 
—

Purchase of non-controlling interest
 
—

 
(4
)
Treasury stock repurchases
 
(186
)
 
(125
)
Net cash used in financing activities
 
(217
)
 
(214
)
 
 
 
 
 
Effect of exchange rate movements
 
(8
)
 
2

 
 
 
 
 
Net increase (decrease) in cash, cash equivalents and restricted cash
 
(59
)
 
(93
)
 
 
 
 
 
Cash, cash equivalents and restricted cash at beginning of period
 
1,388

 
2,254

 
 
 
 
 
Cash, cash equivalents and restricted cash at end of period
 
$
1,329

 
$
2,161

 
 
 
 
 
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet:
 
 
 
 
 
 
 
   Cash and cash equivalents
 
$
1,324

 
$
2,155

   Restricted cash, included in other assets
 
5

 
6

   Total cash, cash equivalents and restricted cash
 
$
1,329

 
$
2,161

 
 
 
 
 
(a) Cash payments included in operating activities:
 
 
 
 
Income tax payments (refunds), net
 
$
286

 
$
104

Interest payments
 
$
39

 
$
36


The preliminary cash flow is estimated based on our current information.

3


AGILENT TECHNOLOGIES, INC.
NON-GAAP NET INCOME AND DILUTED EPS RECONCILIATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
April 30
 
April 30
 
 
 
2020
Diluted
EPS
 
2019
Diluted
EPS
 
2020
Diluted
EPS
 
2019
Diluted
EPS
 
GAAP net income
 
$
101

$
0.32

 
$
182

$
0.57

 
$
298

$
0.95

 
$
686

$
2.13

 
Non-GAAP adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset impairments
 
99

0.32

 
—

—

 
99

0.32

 
—

—

 
Intangible amortization
 
46

0.15

 
26

0.08

 
94

0.30

 
54

0.17

 
Transformational initiatives
 
15

0.05

 
9

0.03

 
28

0.09

 
14

0.04

 
Acquisition and integration costs
 
11

0.03

 
10

0.03

 
24

0.08

 
20

0.06

 
NASD site costs
 
—

—

 
4

0.01

 
—

—

 
6

0.02

 
Special compliance costs
 
—

—

 
1

—

 
—

—

 
1

—

 
Other
 
(29
)
(0.09
)
 
5

0.02

 
(23
)
(0.08
)
 
6

0.02

 
Tax benefit on intra-entity asset transfer
 
—

—

 
—

—

 
—

—

 
(299
)
(0.93
)
 
Adjustment for taxes (a)
 
(20
)
(0.07
)
 
(9
)
(0.03
)
 
(45
)
(0.14
)
 
(16
)
(0.04
)
 
Non-GAAP net income
 
$
223

$
0.71

 
$
228

$
0.71

 
$
475

$
1.52

 
$
472

$
1.47

 

(a) The adjustment for taxes excludes tax benefits that management believes are not directly related to on-going operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. For the three and six months ended April 30, 2020, management used a non-GAAP effective tax rate of 15.5%. For the three months ended April 30, 2019, management used a non-GAAP effective tax rate of 16.48%. For the six months ended April 30, 2019, management used a non-GAAP effective tax rate of 16.75%.

We provide non-GAAP net income and non-GAAP net income per share amounts in order to provide meaningful supplemental information regarding our operational performance and our prospects for the future. These supplemental measures exclude, among other things, charges related to amortization of intangibles, transformational initiatives, acquisition and integration costs, NASD site costs, special compliance costs and tax benefit on intra-entity asset transfer.

Asset impairments include assets that have been written down to their fair value.

Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers including costs to move manufacturing due to new tariffs and tariff remediation actions, small site consolidations, legal entity and other business reorganizations, insourcing or outsourcing of activities. Such costs may include move and relocation costs, one-time termination benefits and other one-time reorganization costs. Included in this category are also expenses associated with company programs to transform our product lifecycle management (PLM) system, human resources and financial systems.

Acquisition and integration costs include all incremental expenses incurred to effect a business combination. Such acquisition costs may include advisory, legal, accounting, valuation, and other professional or consulting fees. Such integration costs may include expenses directly related to integration of business and facility operations, the transfer of assets and intellectual property, information technology systems and infrastructure and other employee-related costs.

NASD site costs include all the costs related to the expansion of our manufacturing of nucleic acid active pharmaceutical ingredients incurred prior to the commencement of commercial manufacturing.

Special compliance costs include costs associated with transforming our processes to implement new regulations such as data privacy regulations, revenue recognition, lease accounting and certain tax reporting requirements.

Other includes certain legal costs and settlements and unrealized gains related to our equity securities in addition to other miscellaneous adjustments.

Tax benefit on intra-entity asset transfer relates to our operations in Singapore along with our application of the new accounting rules for income tax consequences of intra-entity transfer of assets as adopted on November 1, 2018.

Our management uses non-GAAP measures to evaluate the performance of our core businesses, to estimate future core performance and to compensate employees. Since management finds this measure to be useful, we believe that our investors benefit from seeing our results “through the eyes” of management in addition to seeing our GAAP results. This information facilitates our management’s internal comparisons to our historical operating results as well as to the operating results of our competitors.

Our management recognizes that items such as amortization of intangibles can have a material impact on our cash flows and/or our net income. Our GAAP financial statements including our statement of cash flows portray those effects. Although we believe it is useful for investors to see core performance free of special items, investors should understand that the excluded items are actual expenses that may impact the cash available to us for other uses. To gain a complete picture of all effects on the company’s profit and loss from any and all events, management does (and investors should) rely upon the GAAP income statement. The non-GAAP numbers focus instead upon the core business of the company, which is only a subset, albeit a critical one, of the company’s performance.

Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.

The preliminary non-GAAP net income and diluted EPS reconciliation is estimated based on our current information.

4


AGILENT TECHNOLOGIES, INC.
SEGMENT INFORMATION
(In millions, except where noted)
(Unaudited)
PRELIMINARY

Life Sciences and Applied Markets Group
 
 
Q2'20
 
Q2'19
Revenues
 
$
526

 
$
529

Gross Margin, %
 
58.1
%
 
60.6
%
Income from Operations
 
$
98

 
$
107

Operating margin, %
 
18.7
%
 
20.3
%

Diagnostics and Genomics Group
 
 
Q2'20
 
Q2'19
Revenues
 
$
263

 
$
254

Gross Margin, %
 
55.1
%
 
54.8
%
Income from Operations
 
$
57

 
$
49

Operating margin, %
 
21.6
%
 
19.3
%
 
Agilent CrossLab Group
 
 
Q2'20
 
Q2'19
Revenues
 
$
449

 
$
455

Gross Margin, %
 
52.5
%
 
51.3
%
Income from Operations
 
$
122

 
$
115

Operating margin, %
 
27.2
%
 
25.2
%


 

Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, NASD site costs, and special compliance costs.

Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.

The preliminary segment information is estimated based on our current information.

5


AGILENT TECHNOLOGIES, INC.
RECONCILIATION OF REVENUE BY SEGMENT EXCLUDING
ACQUISITIONS, DIVESTITURES AND THE IMPACT OF CURRENCY ADJUSTMENTS (CORE)
(In millions)
(Unaudited)
PRELIMINARY
 
 
Year-over-Year
 




 
 
 
 
 
GAAP
 
 
 
 
 
GAAP Revenue by Segment
Q2'20
Q2'19
Year-over-Year
% Change
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life Sciences and Applied Markets Group
$
526

$
529

(1)%
 
 
 
 
 
Diagnostics and Genomics Group
263

254

3%
 
 
 
 
 
Agilent CrossLab Group
449

455

(1)%
 
 
 
 
 
Agilent
$
1,238

$
1,238

—
 

 
 
 
 
 
 
 
 
 
 
 
 
 
Non-GAAP
(excluding Acquisitions and Divestitures)
 
Year-over-Year at Constant Currency (a)
 
 
Non-GAAP Revenue by Segment
Q2'20
Q2'19
Year-over-Year
% Change
 
Year-over-Year % Change
Percentage Point Impact from Currency
 
Current Quarter Currency Impact (b)
 
 
 
 
 
 
 
 
 
Life Sciences and Applied Markets Group
$
485

$
529

(8)%
 
(7)%
-1 ppt
 
$
(7
)
Diagnostics and Genomics Group
263

254

3%
 
5%
-2 ppts
 
(4
)
Agilent CrossLab Group
449

455

(1)%
 
1%
-2 ppts
 
(9
)
Agilent (Core)
$
1,197

$
1,238

(3)%
 
(2)%
-1 ppt
 
$
(20
)
 
 
 
 
 
 
 
 
 
 
.
We compare the year-over-year change in revenue excluding the effect of recent acquisitions and divestitures and foreign currency rate fluctuations to assess the performance of our underlying business.

(a) The constant currency year-over-year growth percentage is calculated by recalculating all periods in the comparison period at the foreign currency exchange rates used for accounting during the last month of the current quarter, and then using those revised values to calculate the year-over-year percentage change.

(b) The dollar impact from the current quarter currency impact is equal to the total year-over-year dollar change less the constant currency year-over-year change.

The preliminary reconciliation of GAAP revenue adjusted for recent acquisitions and divestitures and impact of currency is estimated based on our current information.

6
 EX-101.SCH 3 a-20200514.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 a-20200514_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 a-20200514_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 a-20200514_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Central Index Key Entity Central Index Key Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Tax Identification Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Amendment Flag Amendment Flag EX-101.PRE 7 a-20200514_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT JSON 8 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-kxq220pressrelea.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "a-20200514_cal.xml" ] }, "definitionLink": { "local": [ "a-20200514_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "form8-kxq220pressrelea.htm" ] }, "labelLink": { "local": [ "a-20200514_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "a-20200514_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "a-20200514.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "a", "nsuri": "http://www.agilent.com/20200514", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form8-kxq220pressrelea.htm", "contextRef": "D2020Q2SD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document and Entity Information Document", "role": "http://www.agilent.com/role/DocumentAndEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form8-kxq220pressrelea.htm", "contextRef": "D2020Q2SD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "a_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.agilent.com/20200514", "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.agilent.com/role/DocumentAndEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Document and Entity Information Document Sheet http://www.agilent.com/role/DocumentAndEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports form8-kxq220pressrelea.htm a-20200514.xsd a-20200514_cal.xml a-20200514_def.xml a-20200514_lab.xml a-20200514_pre.xml exhibit991-q220pressre.htm http://xbrl.sec.gov/dei/2019-01-31 true true XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information Document
May 21, 2020
Document and Entity Information [Abstract]  
Entity Central Index Key 0001090872
Title of 12(b) Security COMMON STOCK, $0.01 PAR VALUE
Entity Incorporation, State or Country Code DE
Document Type 8-K
Document Period End Date May 21, 2020
Entity Registrant Name AGILENT TECHNOLOGIES, INC.
Entity Tax Identification Number 001-15405
Entity Tax Identification Number 77-0518772
Entity Address, Address Line One 5301 Stevens Creek Boulevard
Entity Address, City or Town Santa Clara
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95051
City Area Code (800)
Local Phone Number 227-9770
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Trading Symbol A
Security Exchange Name NYSE
Amendment Flag false
XML 12 form8-kxq220pressrelea_htm.xml IDEA: XBRL DOCUMENT 0001090872 2020-05-21 2020-05-21 false 0001090872 8-K 2020-05-21 AGILENT TECHNOLOGIES, INC. DE 001-15405 77-0518772 5301 Stevens Creek Boulevard Santa Clara CA 95051 (800) 227-9770 false false false false COMMON STOCK, $0.01 PAR VALUE A NYSE false ZIP 13 0001090872-20-000008-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001090872-20-000008-xbrl.zip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inancial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }